Allan Jacobs
Glg Life Tech
GLG-T
DON'T BUY
Nov 24, 2009
Markets a natural sweetener. Fairly big in Asia but small in North America. Sales and earnings are growing quite nicely. Had a couple of hiccups and is ahead of itself. Trading at about 30X next year's earnings and about 13X next year's EBITDA. Also sensitive to a higher Cdn$.
Speculative category. Recently did a financing. Based out of Vancouver but operations in China. They modified Stevia plant to be sweeter than what is otherwise available. Company could see revenues of $200 Million this year.
Have this issue in terms of the China story. Accounting and corporate governance risk. He is concerned about execution risk in China. You can always get back when there is a bounce.
Your Watchlist
Add stocks to watchlist to monitor them daily and get important alerts.